共查询到20条相似文献,搜索用时 62 毫秒
1.
目的:探讨鼻内镜下微波治疗鼻腔后部出血的临床疗效。方法95例鼻腔后部出血患者作为本次的研究对象,所有患者均行鼻内镜下微波治疗,并对其临床资料进行回顾性分析。结果本组95例患者经鼻内镜下微波治疗后83例患者治愈,10例患者有效,2例患者无效,其治疗总有效率为97.9%;其中10例有效患者及2例无效患者经二次微波治疗后均治愈,术后随访3个月,所有患者黏膜均正常,无一例患者发生严重并发症。结论给予鼻腔后部出血患者鼻内镜下微波治疗可取得良好的效果,且不良反应少,有较高的应用价值,可在临床上推广应用。 相似文献
2.
目的 探讨鼻内镜下微波治疗鼻腔后部出血的疗效及临床分析.方法 2010年3月至2012年3月期间,100例鼻出血患者,局麻,在鼻内镜引导下,利用微波的热效应,治疗鼻出血,对其临床疗效和术后并发症,进行观察.结果 100例鼻腔后部出血患者,经过一次鼻内镜微波治疗后,治愈90例,有效8例,无效2例,总有效率为98.0%,8例有效和2例无效患者,经过再次微波治疗后,全部达到治愈标准,术后平均随访3个月,鼻腔黏膜正常,没有出现任何严重并发症.结论 对于鼻腔后部出血患者,鼻内镜下微波治疗具有操作简单、疗效显著并稳定,没有明显不良反应等诸多优点,值得临床推广. 相似文献
3.
4.
5.
6.
目的:对鼻内镜下治疗鼻腔深部出血的临床疗效进行总结和分析。方法选取本院2010年2月-2013年2月期间接治的56例非外伤前鼻镜检查未发现出血点的鼻出血患者的临床资料,患者经过鼻内镜检查后,通过填塞、微波等方法进行止血治疗。结果56例患者经过治疗后均达到了满意的治疗效果,手术之后对患者进行3-6个月的随访发现,所有患者均无复发同侧鼻腔深部出血症状。结论在鼻内镜下对鼻腔深部出血进行治疗的过程中,有清楚的视野,可以准确的检查到出血部位并及时进行止血处理,对于出血位置较为隐蔽的患者尤为适用,值得在临床中推广应用。 相似文献
7.
目的探讨鼻内镜下双极高频电凝止血治疗鼻出血。方法回顾性分析2006年1月至2008年12月289例鼻出血住院患者鼻内镜下的诊治过程。结果289例中235例出血点明确,出血部位以鼻中隔居多158例,下鼻道后穹窿38例,中鼻道后下部11例,下鼻甲前端28例,鼻腔黏膜弥漫性渗血14例,中鼻道上颌窦日出血6例,出血部位不明34例。对其中235例出血部位明确者给以鼻内镜下双极高频电凝止血,226例(96.17%)出血停止,9例仍有少量渗血,给以全身综合治疗后出血止。结论鼻内镜下明确出血部位下给以双极高频电凝止血术能准确到达出血部位,一次性止血成功;鼻出血患者给以个性化、微创干预可有效止血。 相似文献
8.
目的:探讨鼻腔冲洗在鼻—鼻窦炎内镜术后治疗中的应用和效果。方法:选取2007年9月~2010年9月在本院进行鼻内镜术后的284例患者,随机分为治疗组与对照组。治疗组142例进行鼻内镜手术后进行药物鼻腔冲洗和鼻内镜下换药。对照组142例行鼻内镜下鼻腔换药,术后2个月比较两组疗效。结果:治疗组患者术后2个月治愈72例,好转50例,无效20例,总有效率为85.92%。对照组患者治愈46例,好转34例,无效62例,总有效率为56.34%,治愈率与总有效率差异有统计学意义(P〈0.05)。结论:鼻腔冲洗术提高了鼻窦炎的治愈率,减少了术后不良反应。 相似文献
9.
10.
目的探讨较为完善的鼻腔深部出血的治疗方式。方法回顾分析132例鼻内镜检查鼻腔深部出血点选择性局部处理止血的临床资料。结果本组132例患者采取鼻内镜直视下通过微填塞、高频电凝器、止血酶的应用等手段止血,均达到满意止血效果,术后门诊随访1~3个月,均无复发。结论鼻内镜直视下选择局部处理治疗鼻腔深部出血,疗效肯定、优点明显,是治疗鼻深部出血有效、快捷、微创、痛苦小、值得普遍推广的治疗手段,尤其适用于出血位置隐蔽的患者。 相似文献
11.
目的 探讨外伤所致鼻骨骨折患者在鼻内镜下行鼻骨骨折整合与鼻中隔矫正术较传统鼻中隔黏膜下矫正术的优势.方法 选取2014年2月至2017年1月本院耳鼻喉科收治的鼻外伤所致鼻骨伴鼻中隔骨折患者78例进行研究,根据患者手术方式分为A组(鼻内镜下鼻骨骨折整合与鼻中隔矫正术,42例)和B组(传统鼻中隔黏膜下矫正术,36例),比较两组患者手术时间、术后疼痛、住院时间及临床疗效.结果 A组患者手术时间长于B组[(78.6±26.4)min比(51.8±14.9) min],术后1d疼痛评分、住院时间少于B组[(3.1±0.6)比(3.9±0.5),(6.4±1.2)d比(7.9±1.6)d],差异有统计学意义(P<0.05).A组患者治疗效果优于B组(97.62%比80.56%,P< 0.05).结论 外伤所致鼻骨伴鼻中隔骨折患者在鼻内镜下行鼻骨骨折整合与鼻中隔矫正术,相对传统手术可减轻患者手术创伤,提高手术疗效. 相似文献
12.
13.
《中国医药科学》2016,(6):206-208
目的分析经鼻内窥镜下鼻中隔穿孔修补术治疗鼻中隔穿孔的临床效果。方法选取2011年2月~2013年2月收治于我院的40例鼻中隔穿孔患者作为研究对象,并根据术式不同分为观察组和对照组,观察组20例,行双旋转鼻中隔黏膜瓣修补术;对照组20例,行颞肌、骼前上棘阔筋膜修补术。两组手术均经鼻内窥镜下进行,对比两种术式的修复效果。结果观察组患者无需拆线,所有患者呈Ⅰ期愈合,鼻腔通气全部恢复到正常水平,且无再穿孔现象出现。对照组患者需拆线,术后2年有4例患者发生阔筋膜干燥脱落而引发再穿孔,14例患者鼻腔通气恢复到正常水平。结论鼻中隔穿孔患者的修补术式中,双旋转鼻中隔黏膜瓣修补鼻中隔穿孔,其治愈率高、生长效果良好。 相似文献
14.
Yumu?han Günay Fatih Uygur Arzu Atay Bahattin ?elik?z 《Central European Journal of Medicine》2010,5(2):257-260
Severe and composite defects of the nose due to trauma or excision of neoplasms can cause significant functional and aesthetic
problems. It has been known that nasal stents have been used to maintain the nasal patency and nostril shape for a long time.
Recently, nasal prosthesis was introduced as a method to solve aesthetic problems of the patients who had an amputated nose.
In the present study, nasal prosthesis combined with nazal stents was used to camouflage the nasal disfigurement and to maintain
the nasal patency in two adult female patients. Functional and aesthetic results was accepted as satisfactory by both the
patients and the physicians. 相似文献
15.
A G Palma-Carlos M L Palma-Carlos N Rombaut 《International journal of clinical pharmacology research》1988,8(1):25-30
The effect of levocabastine, a new specific H1 antagonist, has been investigated against a placebo in nasal provocation tests on 42 allergic patients divided into two parallel groups. The results obtained show that it significantly inhibited the nasal reaction to the allergen and seems to have a long-lasting effect in allergic patients. 相似文献
16.
眼镜蛇神经毒素粉末剂的鼻黏膜纤毛毒性考察 总被引:2,自引:0,他引:2
目的:考察浙江产眼镜蛇神经毒素鼻用粉末剂(神经毒素粉剂)的鼻黏膜纤毛毒性。方法:以在体蟾蜍上腭模型,观察神经毒素粉剂对鼻纤毛摆动的影响;运用组织病理学方法,在给于家兔神经毒素粉剂后1,3,5,7d时,取鼻中隔黏膜进行光学显微镜观察。结果:神经毒素粉剂抑制鼻纤毛摆动强度,但停止用药后8~9h纤毛摆动可完全恢复,且纤毛形态无明显改变;家兔给予神经毒素粉剂后1,3,5d,其鼻中隔黏膜与空白对照组差异无显著性。第7天,黏膜上皮松化,黏膜轻度充血,但基底膜完整。结论:神经毒素粉剂无急性不可逆性鼻黏膜纤毛毒性。 相似文献
17.
18.
19.
OBJECTIVE: To conduct a cost-effectiveness study of nasal budesonide versus surgical treatment in the management of nasal polyps. DESIGN AND METHODS: A decision-tree model reflecting two different treatment strategies for nasal polyps in Sweden was developed. The first strategy was initial polypectomy, performed under three different sets of circumstances: inpatient functional endoscopic surgery, outpatient evulsion with sedation, or outpatient evulsion with local anaesthesia; all treatments were followed by intranasal treatment with budesonide (Rhinocort) 128 microg twice daily. The second strategy was initial intranasal treatment with budesonide 128 microg twice daily. PERSPECTIVE: Healthcare provider perspective. OUTCOME MEASURES AND RESULTS: After 1 month, treatment with nasal budesonide was classified as a success (82.5%) or a failure (17.5%) based on clinical study data. In cases of success, the treatment was continued, and in cases of failure, polypectomy was undertaken, followed by budesonide 128 microg twice daily. Treatments were evaluated after 4 months using prices from the Central Hospital in Sk?vde, Sweden. The expected reduction in cost from using initial nasal budesonide treatment compared with the different alternatives of polypectomy were 9760 Swedish kronors (SEK) for inpatient functional endoscopic surgery, SEK2747 for outpatient evulsion with sedation, and SEK672 for outpatient evulsion with anaesthesia (1998 values). Nasal budesonide 128 microg twice daily treatment for nasal polyps revealed a potential reduction in costs of 53% compared with the primary surgery approach. CONCLUSION: Initial treatment of nasal polyps with nasal budesonide provides lower costs than treatment with initial polypectomy with maintained effectiveness. 相似文献
20.
The Ussing chamber diffusion system was used as a model to study the apparent permeability across porcine nasal mucosa of eight drugs and molecules with different physicochemical characteristics, namely insulin, lidocaine, nicotine, PEG 4000, propranolol, sumatriptan, melagatran and an amino diether. A weak correlation was found between the apparent permeability coefficients and the corresponding literature data on the fraction absorbed after nasal administration in humans. In the case of passively transported drugs, a closer correlation was found than for the substances where other mechanisms such as carrier-mediated transport or possible efflux were involved. Factors influencing the correlation between in vitro and in vivo data are discussed and the importance of electrophysiological control of the viability status of the excised mucosa is emphasised. Although caution has to be exercised in view of the limitations of the in vitro system, it seems to be a useful tool when evaluating different factors influencing permeability of nasal mucosa. 相似文献